Actively Recruiting
Comparing 24-Hour Active Subperiosteal Drainage Versus Passive Subdural Drainage After Burr Hole Surgery for Chronic Subdural Hematoma in Adults A Nationwide Randomized Clinical Trial in Denmark
Led by Aalborg University Hospital · Updated on 2025-11-25
354
Participants Needed
4
Research Sites
13 weeks
Total Duration
On this page
Sponsors
A
Aalborg University Hospital
Lead Sponsor
O
Odense University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Chronic subdural hematoma CSDH is a common condition often treated by neurosurgical evacuation and drainage of the hematoma. This research aims to compare two drainage methods after surgery 24 hours of active subperiosteal drainage versus 24 hours of passive subdural drainage. The study is a nationwide, randomized clinical trial conducted across all neurosurgical units in Denmark to evaluate if active drainage is not worse than passive drainage in terms of safety and recurrence. Participants will be adults with symptomatic unilateral CSDH undergoing single burr hole evacuation. Before surgery, patients will be randomly assigned to receive either 24 hours of active subperiosteal drainage or 24 hours of passive subdural drainage. Both drainage methods are already in use, but a direct comparison has not been done. The trial will monitor patients for 90 days post-surgery to assess outcomes. During the study, participants will be evaluated for mortality and recurrence of CSDH requiring reoperation within 90 days. Other assessments include complications related to surgery, length of hospital stay, and functional outcomes measured by the simplified modified Rankin scale. The study uses a double-blind design for patients and statisticians and plans to enroll 354 participants over approximately two years.
CONDITIONS
Brief Title
A National Study Examining the Most Effective Drainage Method After Burr Hole Evacuation of Chronic Subdural Hematoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients 18 years or older
- Symptomatic chronic subdural hematoma confirmed by brain CT or MRI
- Admitted to a Danish neurosurgical department for surgical treatment
- Undergoing a single burr-hole evacuation
- Able to give informed written and oral consent prior to surgery
You will not qualify if you...
- Mentally incapacitated patients
- Known abnormalities in cerebrospinal fluid (protein, glucose, cell count, or type)
- Abnormal cerebrospinal fluid dynamics such as obstructive hydrocephalus, normal pressure hydrocephalus, intracranial hypotension, or ventricular peritoneal shunt
- Additional or previous intracranial pathology requiring neurosurgical treatment (e.g., brain tumor, vascular malformation, abscess)
- Recurrent chronic subdural hematoma or previous craniotomy or other transcranial surgery
- Unable to give consent prior to surgery
Research Team
C
Carsten R Bjarkam, Professor, Ph.D., DMSc.
R
Rares Miscov, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here